Journal of Pharmaceutical Sciences 2012-05-01

Estimating relative stability of polymorphs by generation of configurational free energy phase diagram.

Pratik Upadhyay, Ajay K Dantuluri, Lokesh Kumar, Arvind K Bansal

Index: J. Pharm. Sci. 101(5) , 1843-51, (2012)

Full Text: HTML

Abstract

Relationship between two polymorphs is described to be either enantiotropic or monotropic with transition temperature/transition point (T(t) ) below the melting point (T(m) ) of the lower melting form in former case and above the T(m) of the higher melting form in latter case. In the present work, a new methodology for assessing thermodynamic T(t) of two polymorphs has been developed. Configurational free energy (G(c) ) of amorphous with respect to each polymorph was calculated to determine the T(t) . This method was used to determine the T(t) and polymorphic relationship of two model drugs, namely, carbamazepine and nateglinide. This method was also compared with the previous methodologies. Deduced T(t) of carbamazepine using this methodology was compared with previously reported values and was found to be in good agreement. A monotropic relationship was established between nateglinide polymorphs based on T(t) obtained by present methodology and previous reported methodologies.Copyright © 2012 Wiley Periodicals, Inc.


Related Compounds

  • Nateglinide
  • D-Phenylalanine,...

Related Articles:

Formulation and in vitro evaluation of nateglinide microspheres using HPMC and carbopol-940 polymers by ionic gelation method.

2013-11-01

[Pak. J. Pharm. Sci. 26(6) , 1229-35, (2013)]

From evidence assessments to coverage decisions?: the case example of glinides in Germany.

2012-01-01

[Health Policy 104(1) , 27-31, (2012)]

Nateglinide--current and future role in the treatment of patients with type 2 diabetes mellitus.

2005-10-01

[Int. J. Clin. Pract. 59(10) , 1218-28, (2005)]

Efficacy and safety of mitiglinide versus nateglinide in newly diagnose patients with type 2 diabetes mellitus: a randomized double blind trial.

2012-02-01

[Diabetes Obes. Metab. 14(2) , 187-9, (2012)]

Nateglinide (Starlix): update on a new antidiabetic agent.

2003-01-01

[Int. J. Clin. Pract. 57(6) , 535-41, (2003)]

More Articles...